CIK 0001706431 · Large accelerated filer
Vir Biotechnology, Inc.
Sign in to watch- Ticker
- VIR
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 812730369
- Phone
- 415-906-4324
- Business address
- 1800 OWENS STREET, SUITE 900, SAN FRANCISCO, CA, 94158
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $41,939
- in 1 filing, $42K under 10b5-1 plans
Net −$41,939. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 46 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-07-28 | Virgin Herbert EVP, Research & CSO | Option exercise | +7,900 | $1.53 | $12K | 7,900 |
| 2020-07-28 | Virgin Herbert EVP, Research & CSO | Sale | −7,900 | $47.99 | $379K | 0 |
| 2020-07-28 | Virgin Herbert EVP, Research & CSO | Option exercise · Stock Option (Right to Buy) | −7,900 | 508,155 | ||
| 2020-07-15 | Pang Phillip Chief Medical Officer | Option exercise | +10,186 | $1.58 | $16K | 25,963 |
| 2020-07-15 | Pang Phillip Chief Medical Officer | Option exercise | +2,314 | $5.18 | $12K | 28,277 |
| 2020-07-15 | Pang Phillip Chief Medical Officer | Sale | −5,000 | $49.54 | $248K | 23,277 |
| 2020-07-15 | Pang Phillip Chief Medical Officer | Sale | −7,500 | $49.52 | $371K | 15,777 |
| 2020-07-14 | Virgin Herbert EVP, Research & CSO | Option exercise | +7,900 | $1.53 | $12K | 7,900 |
| 2020-07-14 | Virgin Herbert EVP, Research & CSO | Sale | −7,900 | $48.85 | $386K | 0 |
| 2020-07-14 | Virgin Herbert EVP, Research & CSO | Option exercise · Stock Option (Right to Buy) | −7,900 | 516,055 | ||
| 2020-07-13 | Horn Howard CFO | Sale | −30,000 | $50.06 | $1.5M | 177,777 |
| 2020-07-10 | Sigal Charles Elliott Director | Grant or award · Stock Option (Right to Buy) | +28,394 | 28,394 | ||
| 2020-07-10 | Sigal Charles Elliott Director | Grant or award · Stock Option (Right to Buy) | +57,777 | 57,777 | ||
| 2020-07-01 | Pang Phillip Chief Medical Officer | Option exercise · Employee Stock Option (Right to Buy) | −10,186 | 98,147 | ||
| 2020-07-01 | Pang Phillip Chief Medical Officer | Option exercise · Employee Stock Option (Right to Buy) | −2,314 | 74,024 | ||
| 2020-05-21 | SHARP PHILLIP A Director | Grant or award · Stock Option (Right to Buy) | +24,850 | 24,850 | ||
| 2020-05-21 | SATO VICKI L Director | Grant or award · Stock Option (Right to Buy) | +23,649 | 23,649 | ||
| 2020-05-21 | Ramasastry Saira Director | Grant or award · Stock Option (Right to Buy) | +24,497 | 24,497 | ||
| 2020-05-21 | PEREZ ROBERT J Director | Grant or award · Stock Option (Right to Buy) | +24,567 | 24,567 | ||
| 2020-05-21 | Nishar Dipchand Director | Grant or award · Stock Option (Right to Buy) | +24,885 | 24,885 |
Page 53 of 54 · 1,063 trades